Anticancer agent 111

• UNSPSC Description:

  Anticancer agent 111 (compound 11) is a potent cytochrome P450 inhibitor with an IC50 value of 3 μM for CYP3A4. Anticancer agent 111 has anticancer activity. Anticancer agent 111 can be used in research of cancer[1].

• Target Antigen:

  Cytochrome P450

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/anticancer-agent-111.html

• Solubility:

  10 mM in DMSO

• Smiles:

  C[C@@]12[C@@](C/C=C/C[C@]3(O)CCC4C5CCC6=CC(CC[C@]6(C)C5CC[C@]34C)=O)(O)CCC1C7CCC8=CC(CC[C@]8(C)C7CC2)=O

• Molecular Weight:

  628.92

• References & Citations:

  [1]Paquin A, et, al. Investigating a new C2-symmetric testosterone dimer and its dihydrotestosterone analog: Synthesis, antiproliferative activity on prostate cancer cell lines and interaction with CYP3A4. Eur J Med Chem. 2023 Mar 15;250:115222.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  9007-83-4